首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Role of thalassemia screening in prevention and control of thalassemia a 5 year experience
【24h】

Role of thalassemia screening in prevention and control of thalassemia a 5 year experience

机译:地中海贫血筛查在预防和控制地中海贫血中的作用5年经验

获取原文
           

摘要

Background: Thalassemia is a commonest genetic blood disorder in India which can be prevented by antenatal screening and prenatal diagnosis. Aim of the study was to screen antenatal women and their spouses to detect ?couples at risk? of thalassemia major births and offering them genetic counseling and option of prenatal diagnosis thereby preventing the birth of thalassemia major babies. Methods: Thalassemia screening for antenatal women was done by NESTROFT test and RBC Indices (MCV, MCH, and RBC count). Confirmation of diagnosis was done by HPLC test. Husbands of women testing positive on HPLC were also tested and couples at risk detected. They were counseled and referred for prenatal genetic diagnosis. Women carrying thalassemia major fetus were advised termination and those with normal and thalassemia minor fetus were advised to continue pregnancy. Results: A total of 93871 patients were screened and HPLC was done on 10983 patients. 7.07% had one or the other hemoglobinopathies and 5.8% had beta thalassemia trait. Among antenatal beta thalassemia trait was found in 5.02%, HbD in 0.36%, HbE in 0.58% and HbS 0.05%. Forty two ?at risk couples? (both husband and wife thalassemia trait) were identified, 16 of these underwent prenatal diagnosis and 3 thalassemia major births were terminated. Conclusions: Lack of awareness, late registration, husbands not coming/turning up for their test and ?at risk couples? opting out of prenatal diagnosis are the cause of thalassemia major births which can be prevented if awareness is generated amongst masses, screening and prenatal genetic diagnosis services are made widely available.
机译:背景:地中海贫血是印度最常见的遗传性血液病,可以通过产前筛查和产前诊断来预防。该研究的目的是筛查产前妇女及其配偶,以发现“有风险的夫妻”。重型地中海贫血的婴儿,并为他们提供遗传咨询和产前诊断的选择,从而防止重型地中海贫血婴儿的出生。方法:通过NESTROFT试验和RBC指标(MCV,MCH和RBC计数)对产前地中海贫血进行筛查。通过HPLC测试确定诊断。还测试了在HPLC中呈阳性的妇女的丈夫,并检测了有风险的夫妇。他们被咨询并被推荐进行产前基因诊断。建议携带地中海贫血大胎儿的妇女终止妊娠,建议携带地中海贫血小胎儿和正常胎儿的妇女继续妊娠。结果:共筛选了93871例患者,并对10983例患者进行了HPLC。 7.07%的人患有一种或另一种血红蛋白病,5.8%的人患有β地中海贫血。产前β地中海贫血的特征为5.02%,HbD为0.36%,HbE为0.58%,HbS为0.05%。 42对风险夫妇? (丈夫和妻子地中海贫血的特征)均已确定,其中16例接受了产前诊断,终止了3例地中海贫血的主要分娩。结论:缺乏认识,注册较晚,丈夫不来参加考试或有高风险夫妇?选择不进行产前诊断是地中海贫血大产的原因,如果在群众中引起了人们的注意,就可以预防地中海贫血的发生,广泛提供筛查和产前遗传诊断服务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号